Skip to main content

Table 5 Comparison: acute myeloid leukemia (AML) vs solid tumors (STs)

From: Differential cardiac impacts of hematological malignancies and solid tumors: a histopathological and biomarker study

 

AML

(n = 93)a

ST

(n = 164)a

p Value

Demographic parameters

 Age (yrs)

58 (14)

62 (13)

0.032

 Race

  

0.60

 White

74 (80%)

120 (73%)

 

 Black

10 (11%)

20 (12%)

 

 Hispanic

2 (2.2%)

4 (2.4%)

 

 Other Race

7 (7.5%)

20 (12%)

 

 Female

29 (31%)

64 (39%)

0.20

 Body mass index (kg/m2)

31 (9)

28 (8)

0.027

 Tobacco use

55 (63%)

115 (74%)

0.067

Cardiac biomarkers

 Ejection fraction (%)

62 (11)

64 (12)

0.60

 B-type natriuretic peptide (pg/ml)

2,422 (4,770)

867 (1,317)

0.010

 Troponin I (ng/ml)

0.9 (2.4)

4.6 (17.2)

0.055

 Creatine Kinase MB (ng/ml)

5 (11)

12 (29)

0.067

 Hemoglobin (g/dl)

6.73 (0.95)

8.06 (1.97)

 < 0.001

Post-mortem parameters

 Atherosclerosis (more than mild)

31 (40%)

74 (50%)

0.20

 Heart weight (g)

494 (110)

440 (129)

0.001

 Left ventricle thickness (cm)

1.71 (0.39)

1.63 (0.41)

0.19

 Right ventricle thickness (cm)

0.60 (0.25)

0.52 (0.23)

0.039

 Septal wall thickness (cm)

1.52 (0.37)

1.50 (0.39)

0.82

Myocardial morphology

 Collagen fiber alignment

0.66 (0.33)

0.83 (0.12)

0.14

 Interstitial fibrosis (%)

0.23 (0.09)

0.22 (0.08)

0.97

 Cardiomyocyte nuclei (#)

52 (21)

72 (23)

0.002

 Cardiomyocyte minor axis length (µm)

27 (4)

25 (3)

0.065

  1. aValues are mean (SD); n (%)